Photo by Vivu Vietnam on Unsplash
With an expected OTC & Pharma market of USD 16.43 billion in 2040, Vietnam represents a significant opportunity for foreign OTC & Pharma companies with its streamlined regulatory framework and high consumer demand.
A Fast-Rising Healthcare Economy Powered by Reform and Patient/Consumer Demand in Vietnam
Vietnam stands out as one of Asia’s most dynamic Pharma and Consumer health markets.
- GDP per capita has climbed to USD ~4,700, supported by 7–8% annual GDP growth
- A young, increasingly affluent population of over 100 million consumers
- Healthcare spending is expanding quickly as 94% of the population is covered by national health insurance, boosting access to medicines, preventive care, and wellness products.
Regulatory modernization is another strong growth catalyst. Vietnam now adopts ASEAN CTD formats and increasingly accepts ICH-CTD, significantly streamlining drug registration submissions. Moreover, the government continues to simplify administrative steps, reduce bottlenecks, and strengthen transparency, an important shift for global Rx, OTC, phyto, medical device, and life science suppliers. The EVFTA (EU–Vietnam Free Trade Agreement) also supports the importation of innovative medicines by lowering tariffs and aligning standards.
Figure 1: Vietnam’s Pharma Market – Country key facts
A Dual Hospital Landscape Creating New Opportunities
Vietnam operates a dual healthcare system: ~76% public hospitals and ~24% private providers.
- Public hospitals: national, provincial, district, and commune facilities providing affordable care but often face overcrowding.
- Meanwhile, private hospitals are expanding quickly with modern infrastructure, shorter waiting times, and growing specialty services.
This dual structure creates multiple market-entry pathways for pharma and medical device companies, ranging from essential medicine supply in the public sector to premium therapies and diagnostics in private institutions.
Figure 2: Vietnam´s public and private hospital system overview
Pharmacy Retail Transformation: Chains Redefining the Market
Vietnam’s retail pharmacy landscape is shifting from fragmented traditional drugstores toward organized, modern pharmacy chains.
- Long Châu leads the modern retail segment with aggressive nationwide expansion and omnichannel services. More than 1,900 physical stores are serving in big cities as well as rural areas.
- Pharmacity, once the fastest-growing chain, continues to optimize its ~1,000-store network after a restructuring phase.
- An Khang, backed by large retail investors, is rebuilding after consolidation and focusing on profitability.
A major new development is Phuong Hoang (Phoenix), the innovative startup led by the founder of Pharmacity. The concept aims to combine franchise expansion, digital health, and community-level pharmacy services. This signals the next stage of modernization and professionalization in Vietnam’s pharma-retail environment.
How Chameleon Pharma Consulting (CPC) Helps You Succeed in Vietnam
Our CPC regulatory experts can complete the Vietnam drug product registration in approximately 24–28 months, covering Rx/OTC drugs, phyto/herbal medicines, and medical devices—aligned with Vietnam’s evolving CTD standards and dossier expectations.
Moreover, we at CPC are experts in local partner search: identifying reliable MAHs, distributors, pharmacy-chain partners, and hospital-channel players that fit your commercial and compliance goals. With deep regional insights, we ensure your brand enters Vietnam with the right strategy, the right registrations, and the right partnerships.
Contact us today for your individual request at service@chameleon-pharma.com!
About us:
Chameleon Pharma Consulting Group (CPC) has over 20 years of experience in supporting Pharma, OTC, Medical Devices, Phyto, and Aesthetic Medicine companies. Having established own offices & local hubs across Latin America, Europe, Asia, the US/Canada, the Middle East, and the CEE/CIS regions is another advantage of CPC. With this local network and expertise gained from 300+ international projects and a team of 25 experts we offer our clients:
- Business Development, M&A, and Due Diligence
- Market Entry & Expansion: Systematic product and country analysis, market reports
- Strategic Partnering: Identifying local partners, acquisitions, or setting up own offices
- Regulatory & Registration: for drugs, MD, Derma, Aesthetic Medicine, etc.
- Market Authorization & Compliance: Holding MAs, conducting pharmacovigilance
- Quality & Certification: GMP certification, pre-GMP audits
